Sign in
  Edit search
1%2C3-beta-D-glucan in patients receiving intravenous amoxic…
1%2C3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.
1%2C3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.
Article, Chapter
Authors: M.A.S.H. Mennink-Kersten
Publication: New England Journal of Medicine, Volume:354, Issue:26
Published: Massachusetts Medical Society, 2006
ISSN: 0028-4793
  Full text availability for this item
View Full Text Source:New England Journal of Medicine,New England Journal of Medicine,Massachusetts Medical Society Opens in new Window
Journal:  New England Journal of Medicine Source:Massachusetts Medical Society Opens in new Window
Collection:  Massachusetts Medical Society Opens in new Window
Coverage:
  • 1990~present; volume:322~present;issue:1~present
View Full Text Source:New England Journal of Medicine,New England Journal of Medicine,Journals@Ovid Opens in new Window
Journal:  New England Journal of Medicine Source:Journals@Ovid Opens in new Window
Collection:  Journals@Ovid Opens in new Window
Coverage:
  • 1990-01~present; volume:322~present;issue:1~present
View Full Text Source:New England Journal of Medicine,New England Journal of Medicine,Westlaw Journals and Law Reviews - Nijmegen Opens in new Window
Journal:  New England Journal of Medicine Source:Westlaw Journals and Law Reviews - Nijmegen Opens in new Window
Collection:  Westlaw Journals and Law Reviews - Nijmegen
Coverage:
  • 1985~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item